#cell_and_gene_therapy_(CGT) has rapidly evolved from a niche innovation into a mainstream healthcare solution, fundamentally transforming how we diagnose, treat, and manage rare and chronic diseases. By 2025, the adoption of cell and gene therapy has reached a pivotal stage, with an increasing number of approved therapies improving patient outcomes across oncology.
Read More:
https://m2squareconsultancy.co....m/blogs/global-healt
